Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
Replication of equine herpesvirus type 1 (EHV-1) was sensitive to 9-(1,3-dihydroxy-2-propoxymethyl)guanine(DHPG) but relatively resistant to E-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). Likewise, plaque formation by EHV-1 was inhibited by DHPG, but not by BVDU. Plaque formation by a thymidine kinase-negative (tk-) mutant of EHV-1 was not inhibited by DHPG. In order to investigate biochemical mechanisms determining the differential sensitivity of EHV-1 to these drugs, the EHV-1-encoded thymidine kinase enzyme activity (TK)1 was partially purified from EHV-1-infected cells and analyzed. The EHV-1-induced enzyme utilized both ATP and CTP as phosphate donors and differed in relative electrophoretic mobility from the TKs of mock-infected and HSV-1-infected cells. Phosphorylation of 3H-dThd by the EHV-1 TK was inhibited by AraT, IdUrd, BVDU, and DHPG. The EHV-1 TK phosphorylated 125I-dCyd and 3H-ACV. The results indicate that EHV-1 encodes a pyrimidine deoxyribonucleoside kinase with broad nucleoside substrate specificity. These observations suggest that the failure of BVDU to inhibit EHV-1 replication is not attributable to an inability of the EHV-1 TK to phosphorylate BVDU, but may result from the incapacity of the viral TK to convert BVDU monophosphate to the triphosphate or from lack of inhibitory effect of BVDU triphosphate on viral DNA polymerase reactions.
D000212:Acyclovir / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured; D003570:Cytidine Triphosphate / Q000378:metabolism; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D003841:Deoxycytidine / Q000378:metabolism*; D015774:Ganciclovir; D006564:Herpesviridae / Q000201:enzymology*; D004861:Herpesvirus 1, Equid / Q000201:enzymology* / Q000235:genetics / Q000502:physiology; D009154:Mutation; D010766:Phosphorylation; D010770:Phosphotransferases / Q000378:metabolism*; D017853:Phosphotransferases (Alcohol Group Acceptor); D013379:Substrate Specificity; D013937:Thymidine Kinase / Q000378:metabolism*; D014779:Virus Replication / Q000187:drug effects
D003841:Deoxycytidine; C020235:brivudine; D003570:Cytidine Triphosphate; D000255:Adenosine Triphosphate; D010770:Phosphotransferases; C022496:pyrimidine deoxyribonucleoside kinase; D017853:Phosphotransferases (Alcohol Group Acceptor); D013937:Thymidine Kinase; D001973:Bromodeoxyuridine; D015774:Ganciclovir; D000212:Acyclovir